Top 3 Health Care Stocks That May Fall Off A Cliff In October
Option Care Health, Pacira Biosciences and HealthStream show overbought RSI levels above 83, warning momentum-focused investors.
Stocks · News reference
William Blair analyst Matt Larew downgrades Option Care Health (NASDAQ:OPCH) from Outperform to Market Perform.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Option Care Health, Pacira Biosciences and HealthStream show overbought RSI levels above 83, warning momentum-focused investors.
Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor, Energy Transfer buys Vacquero Midstream.
UBS analyst A.J. Rice downgrades Option Care Health (NASDAQ:OPCH) from Buy to Neutral and lowers the price target from $39 to $32.05.